ANCA Vasculitis: Therapeutics

Rituximab pharmacokinetics not associated with response in ANCA-associated vasculitis

MADRID — No association was observed between pharmacokinetic levels of rituximab and clinical…

Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis

Objectives A prospective randomised trial to…

ANCA-negativity prior to maintenance therapy linked with reduced risk for relapse

Anti-neutrophil cytoplasm antibody-negativity prior to maintenance therapy was linked with a…

Relapses Common with S. Aureus Nasal Carriage in ANCA-Related Vasculitis


Image result for S. Aureus Nasal Carriage

Trimethoprim/sulfamethoxazole prophylaxis had no influence on relapse rate